Talha Badar shared a post on X, about recent paper published in Blood Neoplasia:
Authors: Pierre Walczak, Sofiane Fodil, Nicolas Vignal, Aurélie Cabannes-Hamy, Nicolas Boissel, Emmanuel Raffoux, Jean-Michel Cayuela, Lauriane Goldwirt, Etienne Lengliné.
”Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph+ acute lymphoblastic leukemia. Case series of 16 Ph+ ALL, showed sub-optimal CSF concentration of ponatinib.”
Source: Talha Badar/X
Talha Badar, MD, is a specialist in Hematology Oncology based in Mayo Clinic, Jacksonville, Florida. His primary areas of expertise include Leukemia, particularly Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplantation. Over his career, he has actively contributed to clinical research and clinical trials.